Trial Profile
Ticagrelor Versus Clopidogrel for Platelet Inhibition in Patients Undergoing Neurovascular Stenting for Intracranial Aneurysm
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Dec 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
- Indications Thromboembolism
- Focus Therapeutic Use
- Acronyms TIC-TAC
- 04 Dec 2020 Status changed from recruiting to completed.
- 22 Jun 2020 Planned End Date changed from 1 Oct 2020 to 16 Sep 2021.
- 22 Jun 2020 Planned primary completion date changed from 16 Jun 2020 to 16 Jun 2021.